Dr. Brent Robert Bluett, DO

Dr. Bluett practices at Santa Barbara Cottage Hospital in Santa Barbara, California, part of Cottage Health.

Dr. Bluett's NPI, 1669772331, was assigned on October 28, 2010. Dr. Bluett graduated from Touro University Nevada in 2010. Dr. Bluett holds California license 20A13423.

Dr. Bluett's primary practice is Santa Barbara Cottage Hospital, at 400 West Pueblo, Santa Barbara, CA 93105 in Santa Barbara County. The practice phone is (805) 682-7111.

Dr. Bluett's primary practice is Santa Barbara Cottage Hospital in Santa Barbara, California, part of Cottage Health. Dr. Bluett is also affiliated with Goleta Valley Cottage Hospital. Dmand AI also links Dr. Bluett to 1 more hospital, 1 physician office, 1 home health agency and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bluett practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bluett's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bluett is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Bluett is licensed in California.

Dmand AI lists alzheimer's disease, essential tremor, lower back pain, migraine and chronic headache, muscle weakness, neuropathy, parkinson's disease and restless legs syndrome among the conditions Dr. Bluett treats.

CMS data shows 40,094 Medicare services from Dr. Bluett across 10 procedure codes in 2024, for 318 Medicare patients. Medicare paid $379,822 for them. Every service was in an office.

CMS counts 318 Medicare patients who saw Dr. Bluett in 2024. The largest group is 75 to 84, with 166 patients. 75% of them have parkinson's disease, and 74% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bluett's median patient age at 77, with 31% women.

In 2024, Dr. Bluett wrote 4,188 Medicare Part D claims for 373 patients. 86% of them were for generic drugs. CMS names the drug for 4,064 of them, across 32 drugs with 11 or more claims each, at $883,775 in total drug cost. In 2023, CMS named 4,416 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Bluett for performance year 2024, reported individually. Dr. Bluett accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bluett as offering telehealth.

Dmand AI links 18 papers to Dr. Bluett, published from 2011 to 2023. 2018 was the busiest year, with 3. The most frequent topics are Parkinson Disease, Brain and Gait Disorders, Neurologic. Dr. Bluett has published most often in Mov Disord Clin Pract. Dr. Bluett's most frequent co-authors are Amtul Sakina Farheen, MD, Joseph Jankovic, MD and Irene Litvan, MD.

Dmand AI links Dr. Bluett to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Huntington Disease and Chorea. Open Payments lists research payments to Dr. Bluett that name 1 trial.

CMS Open Payments shows 137 general payments to Dr. Bluett from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 51% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $30,639. It also lists 16 research payments totaling $1,429 in 2020, naming 1 clinical trial.

Dr. Bluett graduated from Touro University Nevada in 2010.

Dr. Bluett is in network with 5 carriers, including Blue Cross Blue Shield of Massachusetts, HCSC and Regence Health Plans. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.